Results 21 to 30 of about 1,041,807 (313)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

Sensors, 2021
The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to ...
Dominic A. M. J. Theuns, Sumant P. Radhoe, Jasper J. Brugts   +2 more
doaj   +1 more source

Defibrillation Testing During Defibrillator Implantation [PDF]

Arrhythmia & Electrophysiology Review, 2012
Implantable cardioverter defibrillators (ICDs) terminate ventricular tachycardia (VT) and ventricular fibrillation (VF) with high efficacy. ICDs improve mortality in patients after survived sudden cardiac death (SCD) and in patients at high risk of dying suddenly.
openaire   +2 more sources

Practice Advisory for the Perioperative Management of Patients with Cardiac Implantable Electronic Devices: Pacemakers and Implantable Cardioverter-Defibrillators 2020.

Anesthesiology, 2019
This practice advisory updates the “Practice Advisory for the Perioperative Management of Patients with Cardiac Implantable Electronic Devices: Pacemakers and Implantable Cardioverter–Defibrillators: An Updated Report by the American Society of ...

semanticscholar   +1 more source

Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.

Circulation, 2019
BACKGROUND Patients with end-stage renal disease who are undergoing dialysis are reported to be at high risk of sudden cardiac death (SCD), and to date, no therapy has been shown to be effective in reducing this risk.
J. Jukema, R. Timal, J. Rotmans, Liselotte C. R. Hensen, M. S. Buiten, M. K. de Bie, H. Putter, A. Zwinderman, L. van Erven, M. Jacqueline Krol-van Straaten, N. Hommes, B. Gabreëls, W. V. van Dorp, B. van Dam, Charles A. Herzog, M. Schalij, Ton J. Rabelink   +16 more
semanticscholar   +1 more source

Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar

European Heart Journal, 2018
Aims In patients with non-ischaemic cardiomyopathy (NICM), the mortality benefit of a primary prevention implantable cardioverter-defibrillator (ICD) has been challenged.
S. Gutman, B. Costello, S. Papapostolou, A. Voskoboinik, L. Iles, J. Ja, J. Hare, A. Ellims, P. Kistler, T. Marwick, A. Taylor   +10 more
semanticscholar   +1 more source

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS)

European Heart Journal, 2020
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially lifesaving treatments for a number of cardiac conditions but are not without risk.
C. Blomström-Lundqvist, V. Traykov, P. Erba, H. Burri, J. Nielsen, M. Bongiorni, J. Poole, G. Boriani, Roberto Costa, J. Deharo, L. Epstein, L. Sághy, U. Snygg-Martin, C. Starck, C. Tascini, N. Strathmore   +15 more
semanticscholar   +1 more source

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up

Pacing and clinical electrophysiology : PACE, 2018
Patient satisfaction with remote patient monitoring (RPM) of implantable cardioverter defibrillators (ICDs) seems to be high, yet knowledge on long‐term patient experiences is limited.
Ivy Timmermans, M. Meine, I. Szendey, J. Aring, J. Romero Roldán, L. van Erven, P. Kahlert, E. Zitron, P. Mabo, J. Denollet, H. Versteeg   +10 more
semanticscholar   +1 more source

Challenges of living with an implantable cardioverter-defibrillator: A qualitative content analysis

Nursing and Midwifery Studies, 2022
Background: Living with an implantable cardioverter-defibrillator (ICD) in the body can be challenging for patients. Identifying these challenges is, therefore, crucial for health promotion.
Yaser Moradi, Farzin Mollazadeh, Hossein Jafarizadeh, Hossein Habibzadeh, Rahim Baghaei, Yousef Mohammadpour, Parivash Karimi   +6 more
doaj   +1 more source

Cardiac implantable therapeutic medical devices: A narrative review

Journal of Acute Disease, 2021
Heart diseases are common life-threatening acute diseases. They are leading causes of mortality worldwide, especially significant in developed countries.
Christine Pui Sum Ho, Sunny Chi Lik Au
doaj   +1 more source

Irradiation treatment of laryngeal cancer in a patient with an implantable cardioverter-defibrillator (ICD) [PDF]

, 2007
Background: Due to an aging population the incidence of both cardiac and tumor-related illnesses is increasing. A problem may arise if radiotherapy is necessary in close anatomic proximity to an implantable cardioverter-defibrillator (ICD).
Krimmel, Klaus, Schaffer, Moshe, Schaffer, Pamela Manuela, Sepe, Susanna   +3 more
core   +1 more source